Page last updated: 2024-10-25

clofoctol and Glioma

clofoctol has been researched along with Glioma in 1 studies

Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hu, Y1
Zhang, M1
Tian, N1
Li, D1
Wu, F1
Hu, P1
Wang, Z1
Wang, L1
Hao, W1
Kang, J1
Yin, B1
Zheng, Z1
Jiang, T1
Yuan, J1
Qiang, B1
Han, W1
Peng, X1

Other Studies

1 other study available for clofoctol and Glioma

ArticleYear
The antibiotic clofoctol suppresses glioma stem cell proliferation by activating KLF13.
    The Journal of clinical investigation, 2019, 05-21, Volume: 129, Issue:8

    Topics: Animals; Antibiotics, Antineoplastic; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Chl

2019